This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Xiaomei Feng: Innovator in Cancer Treatment
Introduction
Xiaomei Feng is a notable inventor based in Waltham, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compounds. Her work focuses on creating novel compounds that serve as effective tyrosine kinase inhibitors.
Latest Patents
Xiaomei Feng holds a patent for her invention titled "4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer." This invention relates to novel compounds having the formula (I) and to their pharmaceutical compositions and methods of use. These compounds provide a promising treatment option for cancer patients.
Career Highlights
Xiaomei Feng is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. Her role involves extensive research and development aimed at advancing cancer therapies. With her expertise, she has contributed to the company's mission of delivering innovative medicines to patients.
Collaborations
Xiaomei has collaborated with esteemed colleagues, including Huiping Guan and Ying Kang. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Xiaomei Feng's contributions to cancer treatment through her innovative patents and collaborations highlight her importance in the field of pharmaceutical research. Her work continues to pave the way for advancements in cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile